SCHEMBL30979880

SCHEMBL30979880

COc1ccc2cc(C#N)cnc2c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HPGDS O60760 9/20 1.00
NQO1 P15559 1/20 0.59
EGFR P00533 2/20 0.57
PDGFRB P09619 2/20 0.54
PDGFRA P16234 2/20 0.54
KDM4E B2RXH2 3/20 0.48
CLK1 P49759 3/20 0.48
ALDH1A1 P00352 2/20 0.48
CASP1 P29466 2/20 0.48
HSD17B10 Q99714 2/20 0.48
L3MBTL1 Q9Y468 2/20 0.48
GAA P10253 2/20 0.48
MAPK1 P28482 1/20 0.48
CASP7 P55210 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
GLA P06280 1/20 0.48
HPGD P15428 1/20 0.48
MAPT P10636 1/20 0.45
RXFP1 Q9HBX9 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31297329 1.00 HPGDS (1.00) HPGDSNQO1EGFRPDGFRBPDGFRA
SCHEMBL2201992 1.00 HPGDS (1.00) HPGDSNQO1EGFRPDGFRBPDGFRA
SCHEMBL7504247 0.89 HPGDS (0.81) HPGDSNQO1EGFRPDGFRBPDGFRA
SCHEMBL6990269 0.87 HPGDS (0.77) HPGDSNQO1EGFRPDGFRBPDGFRA
Hydrochloric Acid SCHEMBL29902485 0.86 HPGDS (0.75) HPGDSNQO1EGFRPDGFRBPDGFRA
SCHEMBL4964483 0.84 HPGDS (0.73) HPGDSNQO1PDGFRBPDGFRAKDM4E
SCHEMBL29624688 0.84 HPGDS (0.73) HPGDSNQO1PDGFRBPDGFRAKDM4E
SCHEMBL27555688 0.84 HPGDS (0.72) HPGDSNQO1EGFRPDGFRBPDGFRA
SCHEMBL17327692 0.82 HPGDS (0.69) HPGDSNQO1PDGFRBPDGFRAKDM4E
SCHEMBL28808959 0.79 HPGDS (0.65) HPGDSNQO1EGFRPDGFRBPDGFRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240246940-A1 HETEROARYL DERIVATIVE COMPOUND AND USE THEREOF VORONOI INC. (KR) 2024-07-25 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240246940-A1 HETEROARYL DERIVATIVE COMPOUND AND USE THEREOF ERBB2, EGFR, ERBB3 HPGDS 1648/4885NQO1 667/4885EGFR 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.